Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A prospective randomised study comparing lateral internal sphincterotomy with anal dilatation in the treatment of anal fissures.
ISRCTN ISRCTN40397527
ClinicalTrials.gov identifier
Public title A prospective randomised study comparing lateral internal sphincterotomy with anal dilatation in the treatment of anal fissures.
Scientific title
Acronym N/A
Serial number at source N0084144571
Study hypothesis Are Lateral Internal Sphincterotomy (LIS) and Anal Dilatation for the treatment of anal fissures both acceptable procedures giving equal results?
Lay summary
Ethics approval Not provided at time of registration
Study design Prospective randomised study
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Anal fissure
Participants - inclusion criteria Not provided at time of registration
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 02/06/2003
Anticipated end date 30/06/2004
Status of trial Completed
Patient information material
Target number of participants The aim of this study is to recruit 30 patients in each group to allow for patients lost to follow up and for patients who withdraw from the trial.
Interventions Patients diagnosed as having anal fissure who have been advised to have surgery for the same, and who have agreed to such advice and fulfil the inclusion criteria will be invited to take part in the study until sample size is achieved.

Lateral internal sphincterotomy vs anal dilatation
Primary outcome measure(s) 1. The patient will be required to record all intake of Tramadol on the data collection sheet. The usage of as required medication would be used to calculate the difference in analgesic requirement between the two groups.
2. Anal incontinence will be assessed by the New St. Marks Score, extent of healing will be scored on a scale from 1 to 3, 1=no healing, 3=complete healing.
3. Pain scores on a numerical rating scale 0-10 will be collected from the patient as notes on day 1, day 5 and day 10.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Northern Lincolnshire and Goole Hospitals NHS Trust (UK), NHS R&D Support Funding
Trial website
Publications
Contact name Mr  Muzaffar  Ahmad
  Address Northern Lincolnshire & Goole Hospitals NHS Trust
Scunthorpe General Hospital
Cliff Gardens
  City/town Scunthorpe
  Zip/Postcode DN15 7BH
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 17/11/2010
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central